Safety and efficacy of daratumumab plus bortezomib, lenalidomide, and dexamethasone (D-VRd) vs bortezomib, lenalidomide, and dexamethasone (VRd) in patients with multiple myeloma: A systematic review and meta-analysis.
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Shahzaib Maqbool, Imran Khan, Abdul Rehman, Myhammad Ibrahim, Adil Khan, Momna Nisar, Syed Salman Hamid Hashmi, Pouyan Gohari
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7108440413
Cites:
Cited by:
Related to: